Fortis Oncology is a start-up medical device company developing nanomaterials that preferentially target solid tumor tissue without harming nearby healthy cells, tissues, and organs. Our nanomaterials are activated by light or radio frequency signals that cause the nanoparticles to oscillate at specific levels generating heat sufficient to induce apoptosis (cell death) in vivo.